Mini PROTACs: N-end rule-mediated degradation on the horizon.
Trends Biochem Sci
; 49(1): 5-7, 2024 01.
Article
em En
| MEDLINE
| ID: mdl-37923612
Heterobifunctional proteolysis-targeting chimeras (PROTACs) offer a promising cancer treatment avenue by efficiently degrading unwanted cellular proteins. A recent study from Zhang et al. demonstrated the successful utilization of the N-end rule in PROTAC design, allowing for a modular degradation rate tailored to the oncogenic driver BCR-ABL.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Proteínas
/
Ubiquitina-Proteína Ligases
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article